act_pkpd_eval
【PK/PD 评估】 用户要做药代药效评估、剂量推算 返回:PK/PD 评估结果 (真实算法引擎执行,非大模型生成)
Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| drug_name | Yes | 药物名称 | |
| pk_params | No | 药代参数 |
【PK/PD 评估】 用户要做药代药效评估、剂量推算 返回:PK/PD 评估结果 (真实算法引擎执行,非大模型生成)
| Name | Required | Description | Default |
|---|---|---|---|
| drug_name | Yes | 药物名称 | |
| pk_params | No | 药代参数 |
Changes observed during successful MCP inspections.
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnlyHint=true, destructiveHint=false, and openWorldHint=false, so the safety profile is covered. The description's real contribution is that results come from a '真实算法引擎执行,非大模型生成' — a meaningful statement about determinism and trustworthiness of numeric output. It stops short of describing error behavior, what happens with an unrecognized drug, or the shape/size of the returned result.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
It is a single compact line with the bracketed domain label front-loaded, followed by the trigger and the return statement, so there is no wasted prose. The brevity borders on under-specification rather than verbosity.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
For a computational tool with a free-form nested pk_params object and no output schema, the description should at minimum sketch what the evaluation returns and what the PK parameter object expects. Neither is present, and no prerequisites (e.g., required drug identifiers or units) are stated.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is nominally 100%, so per baseline this sits at 3. However, the descriptions in the schema are bare labels ('药物名称', '药代参数'), and pk_params is an unconstrained nested object whose expected keys are documented nowhere — neither in the schema nor in the tool description. The description adds no parameter meaning at all.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description names a specific domain activity: PK/PD evaluation plus dose estimation (剂量推算), so an agent can tell it is an analysis/computation tool rather than a data-lookup one. It does not, however, differentiate itself from close siblings such as act_pkpd_simulate, act_nca_analyze, or act_dose_convert_pharm, leaving the boundary ambiguous.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The phrase '用户要做药代药效评估、剂量推算' implies a usage trigger (when the user asks for PK/PD assessment or dose calculation) but gives no explicit when-not guidance and names no alternative tool for overlapping cases like simulation or NCA. The agent must infer from sibling names which one to pick.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
Add one secure layer between your agents and this server.